Efor news
5/02/2026
Risk-Based Monitoring and the impact of ICH E6 (R3) on clinical trials
Revision 3 of the Good Clinical Practice guideline (ICH E6 [R3]) was adopted on 6 January 2025 and will take effect on 23 July 202
22/01/2026
Clinical Data Management: The Art of Managing Clinical-Trial Data
This article delves into the fundamentals of Clinical Data Management and shows why it is essential to the success of today’s sc
8/01/2026
Behind every Smart AI is smarter Data Management
Artificial Intelligence (AI) is reshaping industries, influencing decisions from medicine to transportation, finance to entertainm
25/12/2025
Digitalization: Transforming processes to accelerate innovation in Life Sciences
Digitalization has become a crucial strategic lever for companies in the life sciences sector. It involves transforming objects, p
13/11/2025
U.S. Government Shutdown: Consequences for manufacturers and strategic mitigation measures
The U.S. government shutdown has forced multiple federal agencies, including the FDA, to operate with limited resources.
Join our team
Consult our offers
6/11/2025
Thresholds of Toxicological Concern (TTC)
The toxicological risk assessment of a device’s constituents (ISO 10993-17) relies on data obtained either through chemical char
23/10/2025
IT Infrastructure Qualification: Better Risk Management Due to Regulatory Requirements
The qualification process—covering IQ, OQ, and PQ—takes a structured and thorough approach to validating technical components
9/10/2025
Understanding and mastering the differences between clinical evaluation and clinical investigation of medical devices
The distinction between clinical investigations and clinical evaluations is crucial, yet the two terms are still too often confuse
25/09/2025
The evolution of the european regulatory framework regarding electronic instructions for use (EIFU) of medical devices: analysis of regulation (EU) 2025/1234 amending regulation (EU) 2021/2226
Since the adoption of Regulation (EU) 2017/745 on Medical Devices, the European Commission has embarked on a modernization effort
11/09/2025
CLP, REACH and PPWR: Toward Strategic Regulatory Convergence to Support Sustainable Innovation in Life Sciences
The European Union (EU) is undergoing a major overhaul of its strategy on chemical safety, product traceability and environmental
28/08/2025
FDA’s 2025 regulatory shift: integrating sex-specific data across the medical device lifecycle
In 2025, the FDA is enforcing a regulatory revolution: integrating sex-specific differences at every stage of the medical device l
7/08/2025
MDR 2017/745 and IVDR 2017/746: What requirements for what solutions?
This article delves into these regulatory expectations and provides essential insights for navigating this reinforced framework.
